Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard A. Gams, MD
Prologue Research International
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Clinical Research Center
Tucson, Arizona, United States
- Arkansas Cancer Clinic, P.A.
Pine Bluff, Arkansas, United States
- Citrus Valley Medical Center
Covina, California, United States
- Cancer Center and Beckman Research Institute, City of Hope
Duarte, California, United States
- California Cancer Care, Inc.
Greenbrae, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kenmar Research Institute
Los Angeles, California, United States
- Comprehensive Cancer Centers of the Desert
Palm Springs, California, United States
- Kaiser Permanente-Southern California Permanente Medical Group
San Diego, California, United States
- Kaiser Permanente Medical Center - Vallejo
Vallejo, California, United States
- John Muir Medical Center
Walnut Creek, California, United States
- Rocky Mountain Cancer Center
Denver, Colorado, United States
- Northwestern Connecticut Oncology-Hematology Associates
Torrington, Connecticut, United States
- Lombardi Cancer Center
Washington D.C., District of Columbia, United States
- Center for Hematology-Oncology
Boca Raton, Florida, United States
- Halifax Medical Center
Daytona Beach, Florida, United States
- Florida Cancer Specialists
Fort Myers, Florida, United States
- Hematology/oncology Associates
Jacksonville, Florida, United States
- Lake Heart and Cancer Medical Center
Leesburg, Florida, United States
- Oncology-Hematology Group of South Florida
Miami, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- Hematology/oncology Associates
Port Saint Lucie, Florida, United States
- Northwest Medical Specialists, P.C.
Arlington Heights, Illinois, United States
- Dreyer Medical Clinic
Aurora, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Cancer Care Specialists of Central Illinois, S.C.
Decatur, Illinois, United States
- Hope Center
Terre Haute, Indiana, United States
- Medical Oncology and Hematology Associates
Des Moines, Iowa, United States
- Mercy Cancer Center
Mason City, Iowa, United States
- Lucille Parker Markey Cancer Center, University of Kentucky
Lexington, Kentucky, United States
- James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Baton Rouge General Medical Center
Baton Rouge, Louisiana, United States
- Cancer and Blood Institute
Metairie, Louisiana, United States
- Saints Memorial Medical Center
Lowell, Massachusetts, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Medical Oncology Group
Gulfport, Mississippi, United States
- Jackson Oncology Associates, Pllc
Jackson, Mississippi, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Deaconess Billings Clinic
Billings, Montana, United States
- Monmouth Medical Center
Long Branch, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2001
- Primary completion
- 30 Apr 2003
- Completion
- 31 Dec 2010
- Last update posted
- 26 Jun 2013
- Registered enrollment
- —
- Registry id
- NCT00016198
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.